**
Recent investigations have uncovered that fetuses may be exposed to significantly higher concentrations of per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” than previously recognised. A comprehensive analysis conducted by researchers at Mount Sinai examined umbilical cord blood samples, revealing the presence of 42 distinct PFAS compounds, far exceeding earlier estimates.
Comprehensive Analysis Exposes Hidden Risks
Traditionally, the examination of umbilical cord blood has focused on a limited range of PFAS, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, this latest study diverged from conventional methods by employing a non-targeted analytical approach, which scrutinised 120 samples previously thought to contain only a handful of PFAS compounds. The findings illustrated that the total PFAS concentration was considerably greater than initially believed, indicating a broader spectrum of exposure for developing fetuses.
Shelley Liu, a co-author of the study and an associate professor at the Icahn School of Medicine at Mount Sinai, remarked, “Babies are exposed to many more PFAS than we previously thought. It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
The Health Implications of PFAS Exposure
PFAS encompass a class of approximately 15,000 compounds, renowned for their water-, stain-, and grease-resistant properties. These chemicals have been implicated in a range of adverse health outcomes, including cancer, developmental issues, compromised immunity, elevated cholesterol levels, and various chronic diseases. Their moniker, “forever chemicals,” arises from their stability and persistence in both the environment and human biology.
A review encompassing 40 studies has confirmed PFAS detection in 30,000 umbilical cord blood samples, underscoring the pervasive nature of these substances. Elevated maternal PFAS levels have been associated with increased rates of infant mortality, low birth weight, and later-life obesity. Furthermore, prenatal exposure has been correlated with heightened risks of cancer, neurological disorders, and cardiovascular diseases in later stages of life.
Regulatory Oversight Lags Behind Emerging Evidence
Historically, legacy PFAS compounds such as PFOA and PFOS dominated usage until they were largely phased out over the past decade. In their stead, newer generations of PFAS have emerged, which manufacturers often claim are less harmful, yet evidence supporting these assertions remains scant. Alarmingly, PFAS can degrade into new, potentially hazardous compounds once released into the environment or absorbed by the human body.
Regulatory bodies have struggled to keep pace with the evolving landscape of PFAS compounds. The U.S. Environmental Protection Agency (EPA), for instance, employs testing methods that typically assess only 30 to 40 PFAS compounds in water samples, despite independent research identifying thousands. A 2022 analysis revealed that regulatory agencies frequently underestimated PFAS concentrations in water.
The Mount Sinai study juxtaposed traditional analysis methods with its advanced non-targeted approach, confirming a marked increase in detected PFAS levels. Although the EPA has recently certified a blood test capable of detecting 53 compounds, Liu highlighted that the Mount Sinai study identified 31 compounds absent from the EPA’s testing repertoire.
Future Research Directions
While the study did not directly investigate the health ramifications of increased PFAS levels in fetal blood, Liu noted that elevated concentrations are generally linked to an increased risk of health complications. The analysed blood samples were part of the federal government’s Home study, which monitors PFAS exposure and health effects over time. Liu and her colleagues plan to further explore the implications of these findings on infant health.
David Andrews, acting chief science officer at the Environmental Working Group, emphasised the significance of the study, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
This groundbreaking research highlights the urgent need for enhanced regulatory frameworks to protect vulnerable populations, particularly fetuses, from the pervasive threat of PFAS contamination. As the understanding of these chemicals evolves, it becomes paramount to implement robust monitoring and preventative measures to safeguard future generations from the potential health crises linked to these persistent environmental pollutants.
